PHARMACEUTICAL FORMULATION AND COMPOSITION, SEALED CONTAINER, SUBCUTANEOUS ADMINISTRATION DEVICE, KIT, PHARMACEUTICAL UNIT FORM, AND METHOD FOR TREATMENT OF AN INDIVIDUAL SUFFERING TO A DISEASE OR A DISTURAL ASSISTANT
GREGORY A. DEMOPULOS,JOHN STEVEN WHITAKER,KENNETH M. FERGUSON,WILLIAM JOSEPH LAMBERT
申请号:
BR112019003479
公开号:
BR112019003479A2
申请日:
2017.08.30
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The present invention relates to stable, high concentration, low viscosity formulations of masp-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of complement-dependent complement activation. masp-2.a presente invenção refere-se a formulações estáveis, de alta concentração e baixa viscosidade de anticorpos inibitórios de masp-2, a kits compreendendo as formulações e a métodos terapêuticos usando as formulações e kits para a inibição dos efeitos adversos da ativação de complemento dependente de masp-2.